Safety and efficacy of Tranilast for the treatment of relapsed or resistant lymphoid tumors; a pilot study

Trial Profile

Safety and efficacy of Tranilast for the treatment of relapsed or resistant lymphoid tumors; a pilot study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Jan 2014

At a glance

  • Drugs Tranilast (Primary)
  • Indications Lymphoid leukaemia; Lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top